Cytokinetics Inc
- Stock Issuer and Owners
Cytokinetics Inc |
Ticker | CYTK |
CIK # | 0001061983 |
CUSIP | 23282W100 |
Sector | Life Sciences - Pharmaceutical Preparations |
Address | 280 East Grand Avenue, South San Francisco, CA 94080 |
Source |
[EDGAR]
|
Form 13F Holdings |
Firm |
Period |
DFND |
Voting |
Shares |
BlackRock Inc. |
[2023-03-31]
|
SOLE |
14,512,933.0 |
14,625,382.0 |
FMR LLC |
[2023-03-31]
|
DFND |
12,863,209.0 |
12,864,812.0 |
Vanguard Group Inc |
[2023-03-31]
|
SOLE |
0.0 |
9,955,980.0 |
Wellington Management Group LLP |
[2023-03-31]
|
DFND |
0.0 |
7,526,617.0 |
State Street Corp |
[2023-03-31]
|
DFND |
4,551,504.0 |
4,753,900.0 |
American Century Companies Inc |
[2023-03-31]
|
DFND |
2,651,278.0 |
2,678,698.0 |
Polar Capital Holdings Plc |
[2023-03-31]
|
DFND |
2,611,692.0 |
2,611,692.0 |
RTW Investments LP |
[2023-03-31]
|
SOLE |
2,574,198.0 |
2,574,198.0 |
PFM Health Sciences LP |
[2023-03-31]
|
DFND |
0.0 |
2,399,545.0 |
Pictet Asset Management Sa |
[2023-03-31]
|
DFND |
1.0 |
2,270,391.0 |
Lord Abbett & Co LLC |
[2023-03-31]
|
SOLE |
2,195,621.0 |
2,239,421.0 |
Boxer Capital, LLC |
[2023-03-31]
|
OTR |
2,100,000.0 |
2,100,000.0 |
Geode Capital Management LLC |
[2023-03-31]
|
DFND |
1,734,696.0 |
1,734,696.0 |
Janus Henderson Group PLC |
[2023-03-31]
|
DFND |
0.0 |
1,573,644.0 |
T. Rowe Price Investment Management, Inc. |
[2023-03-31]
|
SOLE |
524,554.0 |
1,518,062.0 |
Invesco Ltd. |
[2023-03-31]
|
DFND |
0.0 |
1,477,481.0 |
Artal Group S.A. |
[2023-03-31]
|
DFND |
1,367,023.0 |
1,367,023.0 |
Bank of New York Mellon Corp |
[2023-03-31]
|
DFND |
1,202,010.0 |
1,253,919.0 |
Logos Global Management LP |
[2023-03-31]
|
SOLE |
1,250,000.0 |
1,250,000.0 |
Bank of America Corp /DE/ |
[2023-03-31]
|
DFND |
40,063.0 |
1,203,255.0 |
Price T Rowe Associates Inc /MD/ |
[2023-03-31]
|
SOLE |
239,344.0 |
1,127,037.0 |
Franklin Resources Inc |
[2023-03-31]
|
DFND |
1,082,468.0 |
1,084,644.0 |
Goldman Sachs Group Inc |
[2023-03-31]
|
DFND |
1,031,017.0 |
1,074,524.0 |
Northern Trust Corp |
[2023-03-31]
|
DFND |
73,060.0 |
1,005,691.0 |
Balyasny Asset Management LP |
[2023-03-31]
|
SOLE |
952,004.0 |
952,004.0 |
Farallon Capital Management LLC |
[2023-03-31]
|
OTR |
938,072.0 |
938,072.0 |
Morgan Stanley |
[2023-03-31]
|
DFND |
650,422.0 |
812,244.0 |
Marshall Wace LLP |
[2023-03-31]
|
OTR |
0.0 |
745,307.0 |
Charles Schwab Investment Management Inc |
[2023-03-31]
|
SOLE |
722,681.0 |
722,681.0 |
Nicholas Investment Partners LP |
[2023-03-31]
|
SOLE |
610,990.0 |
610,990.0 |
Prev | Page 1 | Next
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 123491767, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
168749206